Moleculin Biotech (MBRX) Q4 2024 Annual Earnings
MBRX·Reported March 21, 2025·Before market open
Diluted EPS came in at $-0.37, beat the $-1.54 consensus by $1.17.
Diluted EPS
$-0.37beat by $1.17
Consensus: $-1.54
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Moleculin Biotech's Q4 2024 earnings report.
Moleculin Biotech (MBRX) reported Q4 2024 earnings on March 21, 2025 before market open.
Moleculin Biotech reported diluted EPS of $-0.37 for Q4 2024.
EPS beat the consensus estimate of $-1.54 by $1.17.
You can read the 10-K periodic report (0001437749-25-008751) directly on SEC EDGAR. The filing index links above go to sec.gov.